Skip to main content

Table 3 Baseline PET parameters of discovery cohort (patients treated with ipilimumab, n = 70)

From: 18F-FDG PET/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanoma

PET parameter

Mean

Median

Range

IQR

Tumoral SUV max

19.3

16.1

[2.2,71.8]

[11.6,21.5]

SUV mean

6.8

6.1

[1.7, 18.9]

[5.1–7.5]

MTV (mL)

175.2

36.3

[0.03,2693.7]

[12.5167.1]

SLR

0.9

0.9

[0.669, 1.364]

0.81–0.97

  1. PET Positron emission tomography; IQR Interquarter range; SUVmax Maximum Standardised Uptake Value; SUVmean Mean Standardised Uptake Value; MTV Metabolic Tumour Volume; SLR Spleen to Liver Ratio
Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us